Product Information

LAMOTRIGINE 200 MG TABLET is a generic product labeled by Jubilant Cadista Pharmaceuticals Inc., priced at $0.0840 per EA under NDC 59746024860. Its NADAC has been published 548 times since Nov 28, 2013.

FDA first approved this application on Jan 27, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LAMOTRIGINE 200 MG TABLET

Lamotrigine
$0.0840per EA

Strength

200 mg/1

NDC

59746024860

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LAMOTRIGINE

Approval Type

Generic (ANDA)

FDA Application

ANDA079132

FDA Approved

1/27/2009

TE Code

AB

On Market Since

1/27/2009

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity
Dihydrofolate Reductase Inhibitors
Mood Stabilizer
Organic Cation Transporter 2 Inhibitors

Price Statistics

The NADAC for LAMOTRIGINE 200 MG TABLET has been published 548 times since Nov 28, 2013, and over the history we have for it it has declined 14.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0840 per EA
All-time high$0.1122 (Feb 12, 2014)
All-time low$0.0669 (Apr 17, 2019)
52-week high$0.0846
52-week low$0.0787
Median price$0.0834
Average price$0.0854
Largest weekly change-21.4% (Jul 20, 2022)
Weeks tracked548
Tracking sinceNov 28, 2013

Price History

1W

-0.7%

1M

-0.7%

3M

+0.6%

6M

+4.0%

1Y

+7.8%

3Y

+7.8%

5Y

-12.7%

All

-14.6%

Generic Alternatives

The matcher finds 16 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LAMOTRIGINE 200 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LAMOTRIGINE 200 MG TABLET, manufactured by Jubilant Cadista Pharmaceuticals Inc., is $0.0840 per EA (NDC 59746024860), effective Aug 19, 2026.

How has the price of LAMOTRIGINE 200 MG TABLET changed over time?

Over the history we have for it, the NADAC for LAMOTRIGINE 200 MG TABLET has declined 14.6%. It has been tracked across 548 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for LAMOTRIGINE 200 MG TABLET?

Since Nov 28, 2013, the NADAC for LAMOTRIGINE 200 MG TABLET has ranged from a low of $0.0669 (Apr 17, 2019) to a high of $0.1122 (Feb 12, 2014), with a median of $0.0834 per EA.

Are there cheaper alternatives to LAMOTRIGINE 200 MG TABLET?

Yes. 16 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LAMOTRIGINE 200 MG TABLET, is $0.0838 per EA — about 0% below LAMOTRIGINE 200 MG TABLET.

Who manufactures LAMOTRIGINE 200 MG TABLET?

LAMOTRIGINE 200 MG TABLET (NDC 59746024860) is labeled by Jubilant Cadista Pharmaceuticals Inc., and CMS classifies it as a generic product.